1 yıllık getiri (CAGR)
35.78%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
261.44
-1.97 (-0.76%)
HealthcareDrug Manufacturers - General
Loading...
3 yıllık getiri (CAGR)
18.19%
5 yıllık getiri (CAGR)
9.69%
10 yıllık getiri (CAGR)
7.95%
Adobe 2026 3. Çeyrek – Fiyatı piyasa algısı mı belirliyor?
Daha fazla okuPiyasa değeri
618.09B
Fiyat/Satış
6.31
Ent değeri
713.76B
Fiyat/Defter
7.27
DIV kazancı
2.09%
Büyüme yılları
58
DIV büyümesi
5.25%
FCF ödemesi
95.35%
Trailing P/E
29.38
PEG
4.59
İleri P/E
21.19
EPS büyümesi
14.90%
İş anlayişi
Temel Analizin Anlamı ve Metodolojisi (2025)
Daha fazla okuSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...